by Calyptus | Jan 26, 2021 | Investors, Non classéSuccessful IPO of MEDESIS PHARMA, a biotechnology pharmaceutical company, on Euronext Growth Paris® (ISIN: FR0010844464, MNEMO: ALMDP). Visit the Investors section for more information
by Thibaut | Jun 12, 2017 | InvestorsSection reserved for the shareholders of the company
by Thibaut | Jun 12, 2017 | InvestorsMedesis Pharma is planning an introduction to the stock market in the years 2018/2019. Capital increases are made each year to finance all research and development. To invest in the capital of our company, please use the contact section of the site
by Thibaut | Jun 12, 2017 | InvestorsAll capital contributions were exclusively made by private individuals. The company currently has 190 shareholders. We are mainly relying on capital infusions from our shareholders with a cumulated amount of €21 million injected in the Company capital over the last 14...